AOD-9604 vs Tesamorelin vs MOTS-c: What Is the Difference?

The difference between AOD-9604, tesamorelin and MOTS-c is where each acts: AOD-9604 is a 16 amino acid growth hormone fragment studied in fat cell pathways without raising IGF-1, tesamorelin is a 44 amino acid GHRH analogue that makes the pituitary release its own growth hormone, and MOTS-c is a 16 amino acid mitochondrial-encoded peptide that signals through AMPK inside cells. The AOD-9604 vs tesamorelin choice is therefore a choice between two levels of the growth hormone axis, while MOTS-c sits outside that axis entirely.

AOD-9604 vs Tesamorelin vs MOTS-c at a Glance

How Does AOD-9604 Work in Research Models?

AOD-9604 carries the lipid-related tail region of growth hormone as a short looped peptide, so it can be studied in fat cell pathways apart from the hormone's growth actions. Full-length growth hormone is a 191 residue protein that promotes growth, raises IGF-1, affects blood glucose and mobilises stored fat. Work in Australia during the 1990s traced the lipid activity to the C-terminal end of the hormone. AOD-9604 in 2mg and 5mg vials is the result: a 16-mer carrying that tail region, with its two cysteines joined in a disulfide ring. Rodent and adipocyte studies examined it for lipolysis and lipogenesis, and a 2001 paper in Endocrinology used beta-3 adrenergic receptor knockout mice to probe the pathway. For study design, the key property is that it does not engage the growth hormone receptor in a way that drives growth or IGF-1. Development reached phase 2b trials and stopped in 2007, and it holds no registration as a medicine with any regulator.

How Does Tesamorelin Act on the Pituitary?

Tesamorelin binds GHRH receptors on pituitary somatotroph cells, which then secrete growth hormone in pulses and prompt the liver to produce IGF-1. Tesamorelin research peptide copies all 44 residues of human growth hormone-releasing hormone and carries a trans-3-hexenoyl cap on its first tyrosine. That small modification shields the peptide from dipeptidyl peptidase-4, the enzyme that cleaves natural GHRH within minutes. Because the pituitary still controls the output, somatostatin feedback stays intact. A phase 3 trial appeared in 2007 (New England Journal of Medicine), and US registration followed in 2010 for a narrow indication. Laboratories use it as the reference GHRH receptor agonist with a long, well-documented record.

How Does MOTS-c Signal Inside the Cell?

MOTS-c signals by inhibiting the folate cycle, which raises levels of the metabolite AICAR and activates AMPK, the cell's principal energy sensor. MOTS-c mitochondrial peptide has the sequence Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg, encoded inside the mitochondrial gene for 12S ribosomal RNA. The 2015 Cell Metabolism paper that described this mechanism used mice on high-fat diets as the main model. A 2018 follow-up in the same journal reported nuclear translocation of the peptide during metabolic stress, where it influenced nuclear gene activity. It is a tool for studying how mitochondria communicate with the nucleus, a process known as retrograde signalling.

Which Is Better, AOD-9604 or Tesamorelin?

Neither peptide is better in the abstract, because each answers a different research question at a different level of the growth hormone axis. When a study needs to raise endogenous growth hormone and IGF-1 through the pituitary, tesamorelin is the correct tool and AOD-9604 cannot do that job. When the aim is to isolate the lipid-related activity of growth hormone while holding IGF-1 flat, AOD-9604 is the specific probe and tesamorelin would add confounding growth signals.

• Tesamorelin fits GHRH receptor pharmacology, pulsatile growth hormone release and IGF-1 studies.
• AOD-9604 fits studies that separate the metabolic and growth actions of growth hormone.
• Tesamorelin has far more published clinical data, including phase 3; the AOD-9604 record stops at phase 2b.

How Does AOD-9604 Differ From MOTS-c?

AOD-9604 and MOTS-c share a length of 16 residues but come from different genomes, carry different structures and are used to study unrelated pathways. AOD-9604 derives from a pituitary hormone encoded in nuclear DNA and is studied in fat cell pathways from outside the cell. MOTS-c is encoded by mitochondrial DNA and works through intracellular energy sensing via AMPK. The fragment is disulfide-looped with a modest positive charge; MOTS-c is linear, carries three arginines and a lysine, and is strongly basic. In practice the dividing line is the research question: hormone fragment biology on one side, mitochondrial signalling and cellular energy status on the other.

Can AOD-9604 and Tesamorelin Be Used in One Study Design?

Yes, the two can be combined in a research design because they act at different points: tesamorelin on the pituitary GHRH receptor and the fragment on downstream fat cell pathways. A four-arm factorial layout, with control, each peptide alone and both together, shows whether any effect of the pair exceeds each compound on its own. Separate vials are essential so each concentration is set and recorded independently. We do not supply a premixed blend of these two.

Handling and Storage Differences

All three peptides arrive as lyophilised powder, are reconstituted in bacteriostatic water and are held at 2 to 8 °C once mixed. Tesamorelin is the largest and most prone to aggregation, so gentle swirling matters most with it. MOTS-c dissolves readily because of its basic residues, while the fragment sometimes benefits from dilute acetic acid at high concentrations; exact volumes are in how to reconstitute AOD-9604. Sealed vials of each keep best at -20 °C and away from light.

Which Peptide Suits Which Research Question?

We recommend starting from the pathway rather than the compound. For the pituitary axis, tesamorelin is the choice, and it is also supplied as a tesamorelin starter kit with diluent and syringes. For growth hormone fragment biology, AOD-9604 is the choice. For mitochondrial and AMPK work, MOTS-c is the choice. All three are listed in our metabolic research peptide range. HPLC confirms 98% or higher purity on each lot, mass spectrometry confirms identity, and each vial carries its lot number with a matching certificate of analysis. Study lists for each compound are in the tesamorelin research library and the MOTS-c research library.

Questions about AOD-9604 vs tesamorelin

More reading

What Is AOD-9604?Tesamorelin vs Ipamorelin: What Is the Difference?How Do You Reconstitute AOD-9604? Every guide on the research peptide blog

Sources